P12.04 Adherence to clinical guidelines for managing febrile neutropenia inpatients undergoing hematopoietic stem cell transplantation: are weinclined to follow the recommendations of IDSA and NCCN in LMIC?
Main Author: | K Ali |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2024-03-01
|
Series: | Journal for ImmunoTherapy of Cancer |
Similar Items
-
EVALUATION OF USING EMPIRIC GLYCOPEPTIDES IN ACCORDANCE WITH THE IDSA GUIDELINE IN HEMATOLOGIC MALIGNANCY PATIENTS WITH FEBRILE NEUTROPENIA
by: Cumali Yalçın, et al.
Published: (2022-04-01) -
The Guidelines for Febril Neutropenic Patients: The Comparison of Guidelines of IDSA and ECIL
by: Bircan KAYAASLAN
Published: (2016-03-01) -
Evaluation of Febrile Neutropenia in Hospitalized Patients with Neoplasia Undergoing Chemotherapy
by: Maria Bachlitzanaki, et al.
Published: (2023-10-01) -
Update on Febrile Neutropenia in Pediatric Oncological Patients Undergoing Chemotherapy
by: Federica Cennamo, et al.
Published: (2021-11-01) -
Gut diversity and the resistome as biomarkers of febrile neutropenia outcome in paediatric oncology patients undergoing hematopoietic stem cell transplantation
by: Sara Sardzikova, et al.
Published: (2024-03-01)